Latest News

BRISTOL-MYERS SQUIBB: U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Opdivo (nivolumab) received approval from the U.S. Food and Drug Administration (FDA) as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at least one other line of therapy.

4CITE MARKETING: 68 Percent of U.S. Market’s 215 Million Online Shoppers are in 4Cite Data Network

4Cite, the first and only full-service, people-based identification and insights services provider, today announced at eTail East 2018 that 68 percent of the U.S. market’s 215 million online shoppers are a part of the 4Cite Data Network™.

ALTICE USA: The City of Newark’s Summer Youth Employment Program and Altice USA Host Real World Connections Chat with U.S. Senator Cory Booker, Newark Mayor Ras Baraka, and Altice USA CEO Dexter Goei

Altice USA yesterday hosted the Real World Connections Chat with U.S. Senator Cory Booker (D-NJ) and Newark Mayor Ras Baraka in partnership with the City of Newark’s Summer Youth Employment Program together to reinforce the importance of science, technology, engineering and math (STEM) and real-world life experiences for education success.

Metro Business Network